Citations 1
A phase 1 multicenter study evaluating KITE-585, an autologous anti-BCMA CAR T-cell therapy, in patients with relapsed/refractory multiple myeloma.
Cornell, Robert F. , Bishop, Michael R. , Larson, Sarah , Borrello, Ivan , Kumar, Shaji , Rossi, John M. , Thomrongsith, Lisa, Xue, Allen , Roberts, Zachary , Locke, Frederick L. , Bishop, Michael Russell , Orlowski, Robert Z. , Giralt, Sergio , Nooka, Ajay K. , Raje, Noopur
Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: TPS3103-TPS3103
